ImmuONE

ImmuONE is a leader in developing sophisticated in vitro respiratory models that incorporate innate immune responses, specifically targeting alveolar macrophages. The company offers both proprietary products and tailored contract research services, utilizing high-content imaging and multi-endpoint analysis to provide mechanistic safety data for inhaled substances. By addressing a critical gap in traditional epithelial-only models and animal testing, ImmuONE enables more predictive and human-relevant safety assessments for pharmaceuticals, chemicals, and consumer products, supporting a faster and more ethical path to market.

Patented immune-competent in vitro respiratory models (ImmuPHAGE™, ImmuLUNG™) incorporating alveolar macrophages and epithelial cells, coupled with high-content imaging and multi-endpoint analysis (morph_ONE™ assay) for mechanistic safety assessment of inhaled substances.

Operates in a niche within the broader in vitro toxicology and organ-on-a-chip market. Competitors include specialist CROs offering inhalation toxicology services and platform companies developing complex lung models (e.g., Epithelix, MatTek, AlveoliX). ImmuONE differentiates through its specific focus on integrated alveolar macrophage responses and high-content mechanistic analysis.